“GLP-1s cure food addiction”
What the evidence shows
Many people on GLP-1 therapy report a real, sometimes dramatic drop in "food noise" — the intrusive, repetitive thoughts about eating — and GLP-1 receptors are expressed in the brain's reward circuits, which gives a plausible mechanism. Early human data, including small randomized trials, show GLP-1 drugs can reduce cravings and intake for things like alcohol, so the broader "reward" signal is real enough to study seriously.
What we still don’t know
"Food addiction" is not a recognized clinical diagnosis (it is a contested research construct, not in the DSM-5), so there is no defined condition to "cure." We also don't know whether the craving and food-noise effects are durable, whether they persist after stopping the drug, or whether they amount to a treatment for any addictive disorder — the human trials so far are small, short, and early-phase.
Why the claim misleads
"Cure" implies a permanent fix for a defined disease, but neither part holds: food addiction isn't an established diagnosis, and the evidence is early-stage craving reduction that often fades when the drug is stopped — not eradication of a disorder. Framing a quieting of appetite and food thoughts as a "cure" overstates fragile, emerging science and can be genuinely hazardous for people with a disordered-eating history, for whom effortless appetite suppression is a risk rather than a benefit.
Graded by The Peptide Era · evidence, not hype